Latest Healthcare News

Page 12 of 149
BTC Health has broadened its medical product portfolio through strategic acquisitions and organic growth, reporting strong early revenue gains while cautiously navigating the uncertain timing of ECMO system adoption.
Ada Torres
Ada Torres
28 Nov 2025
Singular Health has submitted a 510(k) premarket notification to the FDA for its enhanced 3DICOM MD Cloud platform, aiming to expand imaging capabilities and introduce a scalable, cloud-native solution for medical image management.
Ada Torres
Ada Torres
28 Nov 2025
Cann Group Limited has announced a dramatic 81% reduction in core debt alongside a strategic pivot to higher-margin flower products, positioning the company for its first EBITDA-positive year in FY26.
Ada Torres
Ada Torres
28 Nov 2025
Cann Group Limited has successfully restructured its debt, stabilizing its finances and boosting operational performance, while appointing Mike Ryan as its new Chairman to guide future growth.
Ada Torres
Ada Torres
28 Nov 2025
BTC Health has raised $2 million through a share placement priced at a slight premium, with director Martin Kahanovitz participating and a new South African investor joining the register.
Ada Torres
Ada Torres
28 Nov 2025
TruScreen Group Limited reported a 17% decline in first half FY2026 product sales but affirmed full-year revenue guidance at NZ$2.8 million, supported by strategic expansions and a successful NZ$4 million capital raise.
Ada Torres
Ada Torres
28 Nov 2025
Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.
Ada Torres
Ada Torres
27 Nov 2025
Uscom Limited reported a 25% revenue decline in FY25 amid global geopolitical challenges but reinforced its commitment to growth through strategic partnerships and innovative medical technologies.
Ada Torres
Ada Torres
27 Nov 2025
Hexima Limited reveals plans to return capital to shareholders and restructure its board following the closure of its main clinical program and prolonged ASX trading suspension.
Ada Torres
Ada Torres
27 Nov 2025
SomnoMed Limited reported a robust FY25 with revenue surpassing guidance and a landmark FDA clearance for its Rest Assure® oral device, setting the stage for sustained growth in oral appliance therapy.
Ada Torres
Ada Torres
27 Nov 2025
SDI Limited reported stable FY25 revenue with improved margins and advancing Montrose project, while regional sales showed mixed results.
Ada Torres
Ada Torres
27 Nov 2025
SDI Limited reported a steady FY2025 with a slight profit increase, driven by growth in aesthetic and whitening products and the launch of its new amalgam replacement, Stela. The company also announced plans for a new factory to boost production capacity.
Ada Torres
Ada Torres
27 Nov 2025